PR-Section 8 and 9

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1963 (Rev 05/2006)

OMB No. 0651-0055 (Exp 10/31/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1963 (Rev 05/2006)

OMB No. 0651-0055 (Exp 10/31/2021)

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9

To the Commissioner for Trademarks:

REGISTRATION NUMBER: 3664020
REGISTRATION DATE: 08/04/2009

MARK: KINRIX

The owner, GlaxoSmithKline Biologicals S.A., a corporation of Belgium, having an address of
      Rue de l'Institut 89
      Rixensart, B-1330
      Belgium
      919.315 8204
      919.315.3023
      XXXX (authorized)
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.

For International Class 005, the mark is in use in commerce on or in connection with all goods/services, or to indicate membership in the collective membership organization, listed in the existing registration for this specific class: VACCINES FOR HUMAN USE ; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) a product insert featuring the mark used in direct connection with the goods claimed in the registration..

Original PDF file:
SPN0-15251481-20190321135926181389_._KINRIX_prescribing_information.pdf
Converted PDF file(s) (14 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Specimen File7
Specimen File8
Specimen File9
Specimen File10
Specimen File11
Specimen File12
Specimen File13
Specimen File14
The registrant's current Attorney Information: Angela L. Wilson of  GlaxoSmithKline
      Legal Global Trademarks, Mailstop: 5.5A
      Five Moore Drive
      Research Triangle Park, North Carolina 27709-0183
      United States
The phone number is 919 483-0008.
The fax number is 919.315.3023.
The email address is trademarks@gsk.com. (authorized)
The docket/reference number is REN2015/5024.

The registrant's proposed Attorney Information: Merilee J Arevalo of  GlaxoSmithKline
      LBP, Mailstop: 5.5A
      Five Moore Drive
      Research Triangle Park, North Carolina 27709-3398
      United States The docket/reference number is 81237196.
The Other Appointed Attorney(s): Christopher M Hanes, Terence A Dixon.

The phone number is 919 315 8204.
The fax number is 919.315.3023.
The email address is trademarks@gsk.com. (authorized)
The registrant's current Correspondence Information: ANGELA L. WILSON of  GlaxoSmithKline
      Legal Global Trademarks, Mailstop: 5.5A
      Five Moore Drive
      Research Triangle Park, North Carolina 27709-0183
      United States
The phone number is 919 483-0008.
The fax number is 919.315.3023.
The email address is trademarks@gsk.com. (authorized)
The docket/reference number is REN2015/5024.

The registrant's proposed Correspondence Information: Merilee J Arevalo of  GlaxoSmithKline
      LBP, Mailstop: 5.5A
      Five Moore Drive
      Research Triangle Park, North Carolina 27709-3398
      United States The docket/reference number is 81237196.

The phone number is 919 315 8204.
The fax number is 919.315.3023.
The email address is trademarks@gsk.com. (authorized)

A fee payment in the amount of $425 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.


Declaration

	Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods/services or to indicate membership in the collective membership organization identified above, as evidenced by the attached specimen(s).
	Unless the owner has specifically claimed excusable nonuse, the specimen(s) shows the mark as currently used in commerce on or in connection with the goods/services/collective membership organization.
	The registrant requests that the registration be renewed for the goods/services/collective organization identified above.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of this submission and the registration, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Signature: /Merilee J. Arevalo/    Date: 03/21/2019
Signatory's Name: Merilee J Arevalo
Signatory's Position: Trademark Counsel -member of NJ and PA Bar
Signatory's Phone: 919 315-8204

Mailing Address (current):
   GlaxoSmithKline
   Five Moore Drive
   Research Triangle Park, North Carolina 27709-0183

Mailing Address (proposed):
   GlaxoSmithKline
   Five Moore Drive
   Research Triangle Park, North Carolina 27709-3398

Serial Number: 77009573
Internet Transmission Date: Thu Mar 21 15:15:48 EDT 2019
TEAS Stamp: USPTO/S08N09-XXX.XX.XX.X-201903211515480
28234-3664020-6207e2ce5c290cacd9766bf9b9
a9a3b44292ddb19a8acb16bc0fec56fdbcb16-DA
-1576-20190321135926181389